Vaxzevria significantly boosted antibody levels against Omicron

University of Oxford study supports use of Vaxzevria as third dose booster against Omicron Neutralising antibody levels against Omicron following a third dose boost of Vaxzevria were broadly similar to levels achieved after two doses against the Delta variant AstraZeneca’s Read More …

Vắc xin COVID-19 của AstraZeneca tăng cường đáng kể nồng độ kháng thể chống lại biến thể Omicron

Nghiên cứu từ Đại học Oxford ủng hộ việc sử dụng vắc xin COVID-19 của AstraZeneca làm mũi tiêm thứ 3 tăng cường để chống lại biến thể Omicron Nồng độ kháng thể trung hòa đối với biến thể Omicron Read More …

30 million vaccine doses delivered to Vietnam via AstraZeneca-VNVC partnership

AstraZeneca and Vietnam Vaccine JSC (VNVC) have delivered an additional 1,547,100 doses of COVID-19 Vaccine AstraZeneca (also known as Vaxzevria) to Vietnam, reaching the milestone of 30 million doses and completing the first phase of the companies’ vaccine supply partnership, Read More …

Evusheld (formerly AZD7442) long-acting antibody combination authorised for emergency use in the US for pre-exposure prophylaxis (prevention) of COVID-19

Only antibody therapy authorised in US for pre-exposure prophylaxis   Pivotal phase III data showed robust efficacy and long-term protection with one dose in high-risk population  AstraZeneca’s Evusheld (tixagevimab co-packaged with cilgavimab), a long-acting antibody (LAAB) combination, has received emergency Read More …